Quick Summary
Most founders plan to deal with estate planning after the sale. That instinct is understandable and almost always wrong. The tools available to reduce estate tax are most effective when used before the sale closes, not after. Pre-liquidity assets are valued differently, can be transferred at lower taxable values, and certain trust structures only function correctly when funded before the asset has appreciated to its sale price.
Why Pre-Liquidity Equity Has A Unique Window
Private company equity is difficult to value. There is no market price. Buyers, sellers, and the IRS disagree about what a minority stake in a closely held business is worth. That disagreement creates planning opportunity.
When equity is transferred into a trust or gifted to heirs before a sale, the value used for gift or estate tax purposes is the fair market value of the interest at the time of transfer, not the eventual sale price. A minority interest in a private company frequently qualifies for valuation discounts of 20-40% or more, reflecting lack of control and lack of marketability. That means a $5 million minority stake might transfer at a taxable value of $3 million or less.
If you wait until after the sale closes, that same interest is now cash, worth exactly what it is worth, with no discounts available. The window for discounted transfers closed the moment the deal funded.
Trust Structures That Require Pre-Sale Timing
Several trust strategies are specifically designed to work with pre-liquidity assets. They are not unavailable after a sale, but their economics change substantially, and some stop working entirely.
A Grantor Retained Annuity Trust (GRAT) allows a founder to transfer assets to an irrevocable trust, retain an annuity stream, and pass any appreciation above the IRS hurdle rate to heirs estate-tax-free. With pre-sale equity, the appreciation above that hurdle rate can be enormous, the entire difference between the discount rate and the actual sale price. With post-sale cash, the GRAT must outperform the hurdle rate, which is far harder.
A Charitable Remainder Trust (CRT) allows a founder to contribute appreciated equity, receive an income stream, avoid immediate capital gains on the contribution, and pass the remainder to charity. When funded with pre-sale equity, the CRT can sell the equity without triggering the capital gains that the founder would have owed directly. That is a meaningful acceleration of cash flow, the gains are not eliminated, but they are spread over the annuity period and partially sheltered by the charitable deduction.
An Intentionally Defective Grantor Trust (IDGT) allows a founder to sell equity to the trust in exchange for a promissory note, removing the equity from the taxable estate while keeping the income tax obligation on the grantor. If the equity appreciates after the sale to the trust, that appreciation accrues to heirs gift-tax-free. If the transaction closes before the sale, the trust holds equity that has appreciated to the sale price, and that gain belongs to the trust, not to the estate.
What Changes If You Wait
Founders who address estate planning after the sale face a different set of tools and a narrower window. The equity is gone. What remains is cash or invested assets, both of which are readily valued and fully subject to estate and gift tax at their market value.
Annual exclusion gifting, Roth conversions, and standard trust formation are still available. But the compressed-value transfer window, the ability to move assets at a discounted pre-sale value, has closed. That compression opportunity is only available once, and it is available specifically because the asset has not yet been sold.
Post-sale estate planning is still worth doing. But it is a different conversation, with different use and a different set of achievable outcomes. Founders who do both, who address estate planning before the sale and then revisit the plan after, have a compounding advantage.
The Founder Who Waited, And What It Cost
A founder sells her company for $22 million. Her estate is now $22 million in cash. Her estate attorney tells her that if she had funded a GRAT with her equity 18 months earlier, the appreciation above the IRS hurdle rate, roughly $14 million, could have passed to her children estate-tax-free. Instead, it is sitting in her taxable estate, where the current federal exemption covers most of it, but the exemption is set to sunset in 2026, and the exposure is real.
She is not in a crisis. She has options. But a strong option closed 18 months before the sale.
Starting The Conversation Before The Sale
Estate planning in the context of a founder exit is not a separate conversation from exit planning. It is part of the same conversation. The tax attorney who is analyzing your deal structure and your QSBS eligibility should also be thinking about your estate tax exposure and whether pre-sale trust strategies are worth pursuing.
The timing of that conversation matters more than most founders realize. Trusts take time to set up. Valuations need to be conducted before the sale price is known. Some strategies require a year or more of runway to function correctly. Starting the estate planning conversation at the same time as the exit planning conversation, not after the sale closes, is how founders protect the wealth they worked to create.
Contact Dustin for a confidential conversation about your tax strategy.
